Skip to main content

Allison Casey

News
11/14/2024
According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.
According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.
According to a retrospective...
11/14/2024
Oncology
News
11/12/2024
According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...
According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...
According to a phase 2b trial,...
11/12/2024
Oncology
News
11/11/2024
According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.
According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.
According to results from a...
11/11/2024
Oncology
News
11/07/2024
While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.
While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.
While naporafenib plus...
11/07/2024
Oncology
News
11/05/2024
A single-center real-world study found the use of ipilimumab in the second-line was an effective therapy for patients with metastatic BRAF/NRAS-wildtype metastatic melanoma without brain metastases.
A single-center real-world study found the use of ipilimumab in the second-line was an effective therapy for patients with metastatic BRAF/NRAS-wildtype metastatic melanoma without brain metastases.
A single-center real-world study...
11/05/2024
Oncology
News
11/05/2024
According to a single-center cohort study, there was a substantial overall survival disparity, with differing frequencies of driver gene variations, by race and ethnicity.
According to a single-center cohort study, there was a substantial overall survival disparity, with differing frequencies of driver gene variations, by race and ethnicity.
According to a single-center...
11/05/2024
Oncology
News
07/07/2022
Abiraterone acetate plus prednisone resulted in less fatigue and better health-related quality-of-life for patients with metastatic castration-resistant prostate cancer, but increased glycated hemoglobin and incidence of diabetes when...
Abiraterone acetate plus prednisone resulted in less fatigue and better health-related quality-of-life for patients with metastatic castration-resistant prostate cancer, but increased glycated hemoglobin and incidence of diabetes when...
Abiraterone acetate plus...
07/07/2022
Oncology
News
09/02/2022
Study findings reveal endoscopic ultrasonography demonstrated lower diagnostic accuracy in staging early gastric cancer lesions with ulceration, non-flat morphology, and diameter greater than 2 cm.
Study findings reveal endoscopic ultrasonography demonstrated lower diagnostic accuracy in staging early gastric cancer lesions with ulceration, non-flat morphology, and diameter greater than 2 cm.
Study findings reveal endoscopic...
09/02/2022
Oncology
News
11/17/2022
Study findings reveal laparoscopic surgery is safe and feasible for patients with gastric gastrointestinal stromal tumors sized between 5 and 8 cm, compared to open surgery.
Study findings reveal laparoscopic surgery is safe and feasible for patients with gastric gastrointestinal stromal tumors sized between 5 and 8 cm, compared to open surgery.
Study findings reveal...
11/17/2022
Oncology
Conference Coverage
02/16/2023
According to phase 3 interim data presented at the 2023 ASCO GU Symposium, rucaparib improved radiographic progression-free survival vs either docetaxel or abiraterone/enzalutamide for patients with metastatic castration-resistant prostate...
According to phase 3 interim data presented at the 2023 ASCO GU Symposium, rucaparib improved radiographic progression-free survival vs either docetaxel or abiraterone/enzalutamide for patients with metastatic castration-resistant prostate...
According to phase 3 interim...
02/16/2023
Oncology